Dixon Mitchell Investment Counsel Inc. Has $16.95 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Dixon Mitchell Investment Counsel Inc. lifted its stake in Zoetis Inc. (NYSE:ZTS) by 6.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 86,764 shares of the company’s stock after acquiring an additional 5,067 shares during the period. Dixon Mitchell Investment Counsel Inc.’s holdings in Zoetis were worth $16,952,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of ZTS. Sarasin & Partners LLP lifted its stake in shares of Zoetis by 546.3% in the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock valued at $390,682,000 after buying an additional 1,904,899 shares during the period. Swedbank AB acquired a new stake in shares of Zoetis during the 1st quarter worth approximately $210,815,000. Marshall Wace LLP increased its position in shares of Zoetis by 7,608.6% during the second quarter. Marshall Wace LLP now owns 835,684 shares of the company’s stock valued at $144,874,000 after purchasing an additional 824,843 shares during the period. Vanguard Group Inc. raised its stake in shares of Zoetis by 1.0% in the first quarter. Vanguard Group Inc. now owns 40,749,571 shares of the company’s stock valued at $6,895,235,000 after purchasing an additional 414,605 shares in the last quarter. Finally, Canada Pension Plan Investment Board boosted its stake in Zoetis by 178.2% during the first quarter. Canada Pension Plan Investment Board now owns 639,352 shares of the company’s stock worth $108,185,000 after buying an additional 409,522 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on ZTS shares. Stifel Nicolaus raised their price objective on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. BTIG Research upped their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Argus upgraded Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. JPMorgan Chase & Co. boosted their price target on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Piper Sandler increased their price objective on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Ten investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $221.44.

Zoetis Stock Up 1.2 %

NYSE ZTS opened at $193.37 on Friday. The stock has a market capitalization of $88.23 billion, a P/E ratio of 37.26, a price-to-earnings-growth ratio of 2.99 and a beta of 0.89. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The stock has a fifty day moving average of $188.98 and a 200-day moving average of $176.99.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The company had revenue of $2.36 billion for the quarter, compared to analyst estimates of $2.31 billion. During the same quarter last year, the firm earned $1.41 EPS. The company’s revenue for the quarter was up 8.3% on a year-over-year basis. On average, equities research analysts forecast that Zoetis Inc. will post 5.83 EPS for the current year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be paid a $0.432 dividend. This represents a $1.73 annualized dividend and a yield of 0.89%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s payout ratio is 33.14%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.